| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EMR | Common Stock | Award | +129,422 | +90% | 272,630 | 04 Nov 2024 | Direct | F1, F2, F7 | ||
| transaction | EMR | Common Stock | Tax liability | $6,234,545 | -57,140 | -21% | $109.11 | 215,490 | 04 Nov 2024 | Direct | F3, F4 |
| transaction | EMR | Common Stock | Award | +61,441 | +29% | 276,931 | 04 Nov 2024 | Direct | F5, F6 | ||
| holding | EMR | Common Stock | 149,084 | 04 Nov 2024 | By Trust | ||||||
| holding | EMR | Common Stock | 453 | 04 Nov 2024 | Custodian Account for Son | ||||||
| holding | EMR | Common Stock | 453 | 04 Nov 2024 | Custodian Account for Daughter | ||||||
| holding | EMR | Common Stock | 439 | 04 Nov 2024 | 401(k) plan | ||||||
| holding | EMR | Common Stock | 49 | 04 Nov 2024 | 401(k) excess plan | ||||||
| holding | EMR | Common Stock | 211 | 04 Nov 2024 | Profit Sharing Plan | ||||||
| holding | EMR | Common Stock | 2,107 | 04 Nov 2024 | 401(k) excess plan II |
| Id | Content |
|---|---|
| F1 | Acquisition of shares pursuant to Rule 16b-3 upon payout of 129,422 earned units under a performance share award under a shareholder-approved benefit plan. The payout was based on the level of achievement of financial targets for the performance period ended September 30, 2024. |
| F2 | Price is not applicable to the acquisition described in Note 1. |
| F3 | Shares withheld for required minimum taxes upon vesting of units under a performance share award described in Note 1. |
| F4 | Fair market value on date of withholding described in Note 1. |
| F5 | Grant to Reporting Person of 61,441 restricted stock units under shareholder approved benefit plan pursuant to Rule 16b-3(d). |
| F6 | Price is not applicable to acquisitions resulting from grants of restricted stock units. |
| F7 | Balance reflects increase reported in Form 4/A filed on November 6, 2024. |